These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma. Vasudevan HN; Castro MRH; Lee JC; Villanueva-Meyer JE; Bush NAO; McDermott MW; Solomon DA; Perry A; Magill ST; Raleigh DR Acta Neuropathol Commun; 2020 Jun; 8(1):82. PubMed ID: 32517746 [TBL] [Abstract][Full Text] [Related]
4. Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data. Shetty A; Wang S; Khan AB; English CW; Nouri SH; Magill ST; Raleigh DR; Klisch TJ; Harmanci AO; Patel AJ; Harmanci AS J Neurooncol; 2024 Jul; 168(3):515-524. PubMed ID: 38811523 [TBL] [Abstract][Full Text] [Related]
5. An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures. Collord G; Tarpey P; Kurbatova N; Martincorena I; Moran S; Castro M; Nagy T; Bignell G; Maura F; Young MD; Berna J; Tubio JMC; McMurran CE; Young AMH; Sanders M; Noorani I; Price SJ; Watts C; Leipnitz E; Kirsch M; Schackert G; Pearson D; Devadass A; Ram Z; Collins VP; Allinson K; Jenkinson MD; Zakaria R; Syed K; Hanemann CO; Dunn J; McDermott MW; Kirollos RW; Vassiliou GS; Esteller M; Behjati S; Brazma A; Santarius T; McDermott U Sci Rep; 2018 Sep; 8(1):13537. PubMed ID: 30202034 [TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence. Slavik H; Balik V; Kokas FZ; Slavkovsky R; Vrbkova J; Rehulkova A; Lausova T; Ehrmann J; Gurska S; Uberall I; Hajduch M; Srovnal J Neurosurgery; 2022 Aug; 91(2):360-369. PubMed ID: 35551164 [TBL] [Abstract][Full Text] [Related]
8. Genetic alterations associated with progression and recurrence in meningiomas. Pérez-Magán E; Campos-Martín Y; Mur P; Fiaño C; Ribalta T; García JF; Rey JA; Rodríguez de Lope A; Mollejo M; Meléndez B J Neuropathol Exp Neurol; 2012 Oct; 71(10):882-93. PubMed ID: 22964784 [TBL] [Abstract][Full Text] [Related]
9. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma. Serna E; Morales JM; Mata M; Gonzalez-Darder J; San Miguel T; Gil-Benso R; Lopez-Gines C; Cerda-Nicolas M; Monleon D PLoS One; 2013; 8(6):e67291. PubMed ID: 23840654 [TBL] [Abstract][Full Text] [Related]
11. Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade. Schmidt M; Mock A; Jungk C; Sahm F; Ull AT; Warta R; Lamszus K; Gousias K; Ketter R; Roesch S; Rapp C; Schefzyk S; Urbschat S; Lahrmann B; Kessler AF; Löhr M; Senft C; Grabe N; Reuss D; Beckhove P; Westphal M; von Deimling A; Unterberg A; Simon M; Herold-Mende C Oncotarget; 2016 Mar; 7(12):14551-68. PubMed ID: 26894859 [TBL] [Abstract][Full Text] [Related]
12. Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling. Slavik H; Balik V; Vrbkova J; Rehulkova A; Vaverka M; Hrabalek L; Ehrmann J; Vidlarova M; Gurska S; Hajduch M; Srovnal J Neurosurgery; 2020 Oct; 87(5):1055-1063. PubMed ID: 32125436 [TBL] [Abstract][Full Text] [Related]
13. RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma. Grenier JK; Foureman PA; Sloma EA; Miller AD PLoS One; 2017; 12(10):e0187150. PubMed ID: 29073243 [TBL] [Abstract][Full Text] [Related]
14. Meningioma: current updates on genetics, classification, and mouse modeling. Szulzewsky F; Thirimanne HN; Holland EC Ups J Med Sci; 2024; 129():. PubMed ID: 38571886 [TBL] [Abstract][Full Text] [Related]
15. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas. Trinkaus M; Vranic A; Dolenc VV; Lah TT Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773 [TBL] [Abstract][Full Text] [Related]
16. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203 [TBL] [Abstract][Full Text] [Related]
17. Genomic landscape of meningiomas. Lee Y; Liu J; Patel S; Cloughesy T; Lai A; Farooqi H; Seligson D; Dong J; Liau L; Becker D; Mischel P; Shams S; Nelson S Brain Pathol; 2010 Jul; 20(4):751-62. PubMed ID: 20015288 [TBL] [Abstract][Full Text] [Related]
18. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma. Paramasivam N; Hübschmann D; Toprak UH; Ishaque N; Neidert M; Schrimpf D; Stichel D; Reuss D; Sievers P; Reinhardt A; Wefers AK; Jones DTW; Gu Z; Werner J; Uhrig S; Wirsching HG; Schick M; Bewerunge-Hudler M; Beck K; Brehmer S; Urbschat S; Seiz-Rosenhagen M; Hänggi D; Herold-Mende C; Ketter R; Eils R; Ram Z; Pfister SM; Wick W; Weller M; Grossmann R; von Deimling A; Schlesner M; Sahm F Acta Neuropathol; 2019 Aug; 138(2):295-308. PubMed ID: 31069492 [TBL] [Abstract][Full Text] [Related]
19. A microRNA expression signature predicts meningioma recurrence. Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195 [TBL] [Abstract][Full Text] [Related]
20. Single-cell RNA sequencing identifies macrophage signatures correlated with clinical features and tumour microenvironment in meningiomas. Zhang X IET Syst Biol; 2023 Oct; 17(5):259-270. PubMed ID: 37515398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]